Abbott Laboratories 10-K for FY2023
Abbott Laboratories (ABT)
10-K
2024-02-16
For: 2023-12-31
View Original
Added on
April 11, 2026
About this 10-K
Abbott Laboratories filed this 10-K on February 16, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $40.11B
- down 8.1% from $43.65B a year earlier
- Net income
- $5.72B
- down 17.5% from net income of $6.93B a year earlier
- Diluted EPS
- $3.26
- down 16.6% from $3.91 a year earlier